| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:2162-2170.)
© 1997 American Heart Association, Inc.
Articles |
Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial
From Saint Louis (Mo) University School of Medicine (B.R.C., F.V.A., K.S.); University of Pittsburgh (Pa) (A.D.R., R.M.H., K.D.); Brown University (D.O.W., B.S.), Providence, RI; Montreal Heart Institute (M.G.B.); University of Michigan (B.P.), Ann Arbor; Bowman Gray School of Medicine (P.M.R.), Winston-Salem, NC; University of Alabama (W.J.R.), Birmingham; New York University (M.A.), New York; Mayo Clinic (S.S., R.F.), Rochester, Minn; Washington University (N.T.K.), St. Louis, Mo; and National Heart, Lung, and Blood Institute (G.S.), Bethesda, Md.
Correspondence to Bernard R. Chaitman, MD, FACC, Saint Louis University Health Sciences Center, Division of Cardiology (13th Floor), 3635 Vista Ave at Grand Blvd, PO Box 15250, St. Louis, MO 63110-0250. E-mail chaitman{at}sluvca.slu.edu
Background Cardiac mortality and myocardial infarction (MI) rates are used to evaluate the efficacy of coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA). We compared 5-year cardiac mortality and MI rates in 1829 patients with multivessel disease randomized to CABG or PTCA.
Methods and Results The 5-year cardiac mortality rate was 8.0% in patients assigned to PTCA compared with 4.9% in those assigned to CABG (relative risk [RR] of 1.55 with a 95% confidence interval [CI] of 1.07 to 2.23; P=.022). In a subgroup of 1476 nondiabetic patients, there were no significant differences between treatment groups in cardiac mortality either overall (4.6% versus 4.2%; RR=1.04, 95% CI, 0.65 to 1.66; P=.908) or in subgroups based on symptoms, left ventricular function, number of diseased vessels, or stenotic proximal left anterior descending artery. The two treatment groups had similar event rates for the combined end point of cardiac death or MI. The RR for cardiac mortality in 264 patients who sustained an MI compared with those who did not was 5.9 (P<.001). MIs were more common after CABG during index hospitalization (P=.004), but in the PTCA group, they were more common after discharge (P<.001).
Conclusions The Bypass Angioplasty Revascularization Investigation (BARI) trial indicates 5-year cardiac mortality in patients with multivessel disease was significantly greater after initial treatment with PTCA than with CABG. The difference was manifest in diabetic patients on drug therapy. There were no significant differences overall for the composite end point of cardiac mortality or MI between treatment groups or for cardiac mortality in nondiabetic patients regardless of symptoms, left ventricular function, number of diseased vessels, or stenotic proximal left anterior descending artery.
Key Words: bypass • angioplasty • mortality • myocardial infarction • prognosis
This article has been cited by other articles:
 |
|
 |
|
  A. Aziz, A. M. Lee, M. K. Pasque, J. S. Lawton, N. Moazami, R. J. Damiano Jr, and M. R. Moon Evaluation of Revascularization Subtypes in Octogenarians Undergoing Coronary Artery Bypass Grafting Circulation, September 15, 2009; 120(11_suppl_1): S65 - S69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med, November 20, 2007; 147(10): 703 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The BARI Investigators The Final 10-Year Follow-Up Results From the BARI Randomized Trial J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1600 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Hannan, M. J. Racz, G. Walford, R. H. Jones, T. J. Ryan, E. Bennett, A. T. Culliford, O. W. Isom, J. P. Gold, and E. A. Rose Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation N. Engl. J. Med., May 26, 2005; 352(21): 2174 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF]
|
|
|
|
|
|
M. Shechter, S. Matetzky, M. S. Feinberg, P. Chouraqui, Z. Rotstein, and H. Hod External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2090 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Bridges Cardiac surgery in African Americans Ann. Thorac. Surg., October 1, 2003; 76(4): S1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Hoffman, J. A. TenBrook Jr, M. P. Wolf, S. G. Pauker, D. N. Salem, and J. B. Wong A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1293 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Mooradian Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines Arch Intern Med, January 13, 2003; 163(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.S. Srinivas, M. M. Brooks, K. M. Detre, S. B. King III, A. K. Jacobs, J. Johnston, and D. O. Williams Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study Circulation, September 24, 2002; 106(13): 1627 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stys, W. E. Lawson, J. C. K. Hui, G. Lang, J. Liuzzo, and P. F. Cohn Acute Hemodynamic Effects and Angina Improvement with Enhanced External Counterpulsation Angiology, October 1, 2001; 52(10): 653 - 658. [Abstract] [PDF]
|
|
|
|
|
|
R. J. Gibbons, D. D. Miller, P. Liu, P. Guo, M. M. Brooks, and M. Schwaiger Similarity of Ventricular Function in Patients Alive 5 Years After Randomization to Surgery or Angioplasty in the BARI Trial Circulation, February 27, 2001; 103(8): 1076 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Urano, H. Ikeda, T. Ueno, T. Matsumoto, T. Murohara, and T. Imaizumi Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease J. Am. Coll. Cardiol., January 1, 2001; 37(1): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.K McGuire, H Emanuelsson, C.B Granger, E Magnus Ohman, D.J Moliterno, H.D White, D Ardissino, J.W Box, R.M Califf, and E.J Topol Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study Eur. Heart J., November 1, 2000; 21(21): 1750 - 1758. [Abstract] [PDF]
|
|
|
|
|
|
R. Sciagra, M. Pellegri, A. Pupi, L. Bolognese, G. Bisi, V. Carnovale, and G. M. Santoro Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., September 1, 2000; 36(3): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Brooks, R. H. Jones, R. G. Bach, B. R. Chaitman, M. J. Kern, T. A. Orszulak, D. Follmann, G. Sopko, E. H. Blackstone, and R. M. Califf Predictors of Mortality and Mortality From Cardiac Causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry Circulation, June 13, 2000; 101(23): 2682 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
K. E. Kip, M. G. Bourassa, A. K. Jacobs, L. Schwartz, F. Feit, E. L. Alderman, B. H. Weiner, M. B. Weiss, M. A. Kellett Jr, B. L. Sharaf, et al. Influence of Pre-PTCA Strategy and Initial PTCA Result in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI) Circulation, August 31, 1999; 100(9): 910 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Arora, T. M. Chou, D. Jain, B. Fleishman, L. Crawford, T. McKiernan, and R. W. Nesto The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1833 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Olinger Informed advice Ann. Thorac. Surg., June 1, 1999; 67(6): 1545 - 1546. [Full Text] [PDF]
|
|
|
|
|
|
H. Satre, L. Holmvang, G.S. Wagner, B. Lindahl, and L. Wallentin Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease Eur. Heart J., May 1, 1999; 20(9): 645 - 652. [Abstract] [PDF]
|
|
|
|
|
|
M. G. Bourassa, K. E. Kip, A. K. Jacobs, R. H. Jones, G. Sopko, A. D. Rosen, B. L. Sharaf, L. Schwartz, B. R. Chaitman, E. L. Alderman, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI) J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1627 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Kuntz Importance of Considering Atherosclerosis Progression When Choosing a Coronary Revascularization Strategy : The Diabetes–Percutaneous Transluminal Coronary Angioplasty Dilemma Circulation, February 23, 1999; 99(7): 847 - 851. [Full Text] [PDF]
|
|
|
|
|
|
M. Sousa Uva, E. Braunberger, M. Fisher, Y. Fromes, P. H. Deleuze, J. A. Celestin, and O. M. Bical Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? Ann. Thorac. Surg., December 1, 1998; 66(6): 2051 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. King III Is It Important How One Dies? : Questions for Planning Future Revascularization Trials Circulation, October 7, 1997; 96(7): 2121 - 2123. [Full Text]
|
|